ORYZON GENOMICS S.A.

Insiders Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Real-time Estimate Tradegate Other stock markets 04:31:41 2024-05-14 am EDT			5-day change	1st Jan Change
2.013 ^EUR	+3.12%		+3.48%	+6.99%

May. 06	Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 22	Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ORYZON Announces Clinical Candidate Nomination of ORY-4001 for the Treatment of CNS Disorders	23-03-13	AQ
Oryzon Genomics, S.A. Announces Clinical Candidate Nomination of ORY-4001 for the Treatment of CNS Disorders	23-03-13	CI
Oryzon Genomics S.A. Announces Appointment of Douglas V. Faller as Global Chief Medical Officer	22-03-28	CI
Oryzon Genomics S.A. Appoints Ana Limón as Senior Vice President of Clinical Development and Global Medical Affairs	22-01-11	CI
Oryzon Genomics S.A. Appoints Saikat Nandi Has Been Appointed as Global Chief Business Officer	21-11-22	CI
Oryzon Genomics S.A. Announces Executive Changes	20-11-02	CI
Oryzon Genomics S.A. Announces Board Changes	20-05-11	CI
Oryzon Genomics S.A. Appoints Vanessa Almendro Navarro to Board of Directors	20-04-17	CI
Oryzon Genomics Appoints Michael T. Ropacki as Vice President of Clinical and Product Development	19-01-07	CI
Oryzon Genomics Announces Changes to its Board of Directors	18-02-20	CI
Oryzon Genomics Appoints Lori A. Kunkel as a Scientific Advisor	18-02-05	CI
Oryzon Genomics Announces Executive Changes	17-05-16	CI
Oryzon Genomics Appoints Board of Directors	15-11-04	CI
Oryzon Genomics SA Appoints Greg Weaver as Executive Vice President and Global Chief Financial Officer	15-01-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW